Jeffrey John Thramann Auddia Inc. (AUUD) insider trading activity

Jeffrey John Thramann is CEO and Executive Chairman of AUDDIA INC.. Currently has a direct ownership of 2,356 shares of AUUD, which is worth approximately $2,756. The most recent transaction as insider was on Dec 31, 2025, when has been sold 2,301 shares (Common Stock) at a price of $0.96 per share, resulting in proceeds of $2,208. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.36K

97.02% 3M change

99.88% 12M change

Total Value Held $2,756

Jeffrey John Thramann Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 31 2025	SELL Open market or private sale	$2,208 $0.96 p/Share	2,301 Reduced 49.41%	2,356 Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$351 $0.51 p/Share	690 Reduced 0.86%	79,146 Common Stock
Feb 16 2025	BUY Exercise of conversion of derivative security	-	2,000 Added 2.44%	79,836 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$6,641 $0.22 p/Share	30,188 Reduced 1.53%	1,945,895 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	87,500 Added 4.24%	1,976,083 Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$78,579 $1.08 p/Share	72,759 Reduced 3.71%	1,888,583 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	220,483 Added 10.11%	1,961,342 Common Stock

Jul 14 2022	BUY Open market or private purchase	$6,435 $0.99 p/Share	6,500 Added 0.37%	1,740,859 Common Stock
Jul 12 2022	BUY Open market or private purchase	$2,400 $0.96 p/Share	2,500 Added 0.14%	1,734,359 Common Stock
Feb 16 2022	SELL Payment of exercise price or tax liability	$44,379 $1.79 p/Share	24,793 Reduced 1.41%	1,731,859 Common Stock
Feb 16 2022	BUY Exercise of conversion of derivative security	-	75,000 Added 4.09%	1,756,652 Common Stock
Feb 16 2021	SELL Open market or private purchase	$3,995,152 $4.12 p/Share	969,697 Reduced 36.56%	1,682,349 Common Stock

Also insider at

ACON

Aclarion, Inc. Healthcare

Executive Chairman

JJT